<?xml version="1.0" encoding="UTF-8"?>
<p id="p0225">Towards speeding up vaccine development, the number of people needed to be included in clinical trials was discussed. The classic number of people in safety studies is at least 3000 people but this may depend on the vaccine platform, and how well characterized the platform is for safety.</p>
